Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Clinical trial NCT01185366 · TERMINATED
Trial details
- NCT number
- NCT01185366
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2019-09-09
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.